Supplementary Data from Leveraging Therapy-Specific Polygenic Risk Scores to Predict Restrictive Lung Defects in Childhood Cancer Survivors

MLA

Yutaka Yasui, et al. Supplementary Data from Leveraging Therapy-Specific Polygenic Risk Scores to Predict Restrictive Lung Defects in Childhood Cancer Survivors. Mar. 2023. EBSCOhost, https://doi.org/10.1158/0008-5472.22432373.v1.

APA

Yutaka Yasui, Daniel A. Mulrooney, Leslie L. Robison, Melissa M. Hudson, Gregory T. Armstrong, Carmen L. Wilson, Kirsten K. Ness, Zhaoming Wang, Yadav Sapkota, Andrew M. Davidoff, Matthew J. Krasin, Dennis C. Stokes, Eric D. Austin, Yan Yuan, & Cindy Im. (2023). Supplementary Data from Leveraging Therapy-Specific Polygenic Risk Scores to Predict Restrictive Lung Defects in Childhood Cancer Survivors. https://doi.org/10.1158/0008-5472.22432373.v1

Chicago

Yutaka Yasui, Daniel A. Mulrooney, Leslie L. Robison, Melissa M. Hudson, Gregory T. Armstrong, Carmen L. Wilson, Kirsten K. Ness, et al. 2023. “Supplementary Data from Leveraging Therapy-Specific Polygenic Risk Scores to Predict Restrictive Lung Defects in Childhood Cancer Survivors,” March. doi:10.1158/0008-5472.22432373.v1.